Author

A. Llop-Guevara

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Assay:proteomics· 1

Frequent Co-Authors

V. Serra· 2 shared A. Vivancos· 1 shared A. Wilkinson· 1 shared A. Yong· 1 shared C. E. Caldon· 1 shared C. Lee· 1 shared C. M. Sergio· 1 shared C. Suarez· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

V. Serra

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Evaluation of homologous recombination repair status in metastatic prostate cancer by next-generation sequencing and functional tissue-based immunofluorescence assays

S. Arce-Gallego, P. C. Morgado, L. Delgado-Serrano, S. Simonetti, M. Gonzalez, D. Marmolejo, R. Morales-Barrera, G. Mir, M. E. Semidey, P. R. Lozano, S. Cordoba-Terreros, R. Mast, M. de Albert, J. Planas, M. Cuadras, , J. Mateo

This study evaluates homologous recombination repair status in metastatic prostate cancer using next-generation sequencing and RAD51 immunofluorescence assays, finding strong correlation between genomic and functional HRR loss.

bioRxiv · Jan 28, 2024Cancer Biology

Cyclin E1 protein is stabilized in BRCA1 mutated breast cancers leading to synergy between CDK2 and PARP inhibitors

D. Aziz, N. Portman, K. Fernandez, C. Lee, S. Alexandrou, A. Llop-Guevara, A. Yong, A. Wilkinson, C. M. Sergio, D. Ferraro, D. Etemadmoghadam, D. Bowtell, k. Investigators, V. Serra, P. Waring, , C. E. Caldon

The paper identifies cyclin E1 stabilization in BRCA1-mutated breast cancers and shows synergy between CDK2 and PARP inhibitors in treating these cancers.

bioRxiv · Jan 29, 2020Cancer Biology